1.5900
0.0000
(0.00%)
As of January 30 at 3:00:00 PM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-35,544.0000
-34,671.0000
-20,303.0000
-25,909.0000
-28,742.0000
Investing Cash Flow
15,227.0000
34,572.0000
20,272.0000
-5,789.0000
17,742.0000
Financing Cash Flow
31,517.0000
11,369.0000
-1,477.0000
32,320.0000
14,941.0000
End Cash Position
14,920.0000
15,666.0000
4,403.0000
5,911.0000
5,277.0000
Capital Expenditure
-3,328.0000
-2,746.0000
-1,535.0000
-686.0000
-852.0000
Issuance of Capital Stock
--
--
--
34,129.0000
--
Issuance of Debt
--
12,859.0000
--
--
--
Repayment of Debt
--
--
--
-197.0000
-11,406.0000
Free Cash Flow
-38,872.0000
-37,417.0000
-21,838.0000
-26,595.0000
-29,594.0000
12/31/2020 - 1/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
4DN.F Denali Therapeutics Inc.
22.59
+0.89%
BOVNF BioInvent International AB (publ)
4.7000
0.00%
HNSBF Hansa Biopharma AB (publ)
3.0000
0.00%
SNBIF SanBio Company Limited
4.6500
0.00%
GNNSF Genscript Biotech Corporation
1.3550
0.00%
ASCLF Ascletis Pharma Inc.
0.2393
0.00%
MLLCF Molecular Partners AG
4.2200
0.00%
PBIGF Paradigm Biopharmaceuticals Limited
0.3280
0.00%
OXBDF Oxford Biomedica plc
5.56
0.00%
IPHYF Innate Pharma S.A.
2.9000
0.00%